ClinicalTrials.gov
public full text
Public Domain
Combination of Sorafenib and Radiation for Brain Metastases and Primary Brain Tumors
Sorafenib™ has the potential to inhibit tumor growth, tumor angiogenesis , and enhance radiation response. This study will test the combination of Sorafenib™ and radiation therapy with or without temozolomide to determine tolerance of the combined treatments. Defining safe dosing of Sorafenib™ in this combination therapy will be achieved.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain#1231257
- Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma#897598
- Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung Cancer#1094318
- Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors#1140413
- A Study of Radiation With Sorafenib in Advanced Cancer#1087482
Record · ID 1351009
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive